Primary or Secondary Hyperparathyroidism: Why Does the Cause Change the Treatment Path?

The printout is two pages long, and one line is circled in blue ink: calcium, slightly above the reference range. A second line, parathyroid hormone, sits just above its range too. The person holding the paper had come in about a routine kidney stone. Now a physician is saying a word they have never heard, and the next sentence is either “we may talk about surgery” or “we need to look at your kidneys and your vitamin D first.”

That fork in the road is the whole story of primary vs secondary hyperparathyroidism. Two diagnoses share a name, a hormone, and often a similar level of worry in the waiting room. Yet one is a gland misbehaving on its own, and the other is a gland doing exactly what it was designed to do in response to a problem elsewhere in the body.

Understanding which one you have changes what gets treated, in what order, and by whom. That is worth twenty minutes of plain explanation.

What the parathyroid glands actually do, in plain language

Behind the thyroid, in the front of the neck, sit four glands each about the size of a grain of rice. These are the parathyroid glands, and despite the shared name they have nothing to do with metabolism or thyroid hormone. Their single job is to keep the level of calcium in the blood inside a narrow band.

They do this with parathyroid hormone, or PTH, a chemical messenger released when calcium drifts low. PTH has three levers. It signals bone to release stored calcium into the bloodstream. It tells the kidneys to hold on to calcium rather than lose it in urine, and to shed phosphate instead. And it prompts the kidneys to convert vitamin D into its active form, which in turn helps the gut absorb more calcium from food. When calcium rises back to target, PTH release falls. The system behaves like a household thermostat: the furnace runs when the room is cold and shuts off when it is warm.

Calcium matters because nerves, muscles, and the heart’s electrical system all depend on it minute by minute. The body will sacrifice bone, its long-term calcium bank, to protect the short-term blood level. That trade-off explains why parathyroid disorders so often surface as thinning bones or kidney stones rather than as a symptom you can feel in the neck.

Hyperparathyroidism simply means the glands are releasing too much PTH. The crucial question, and the one that shapes every decision afterward, is whether the thermostat itself is broken or whether the room is genuinely cold. According to the National Institute of Diabetes and Digestive and Kidney Diseases, that distinction separates the primary form from the secondary form, and it is usually visible in a handful of blood tests before anyone touches an imaging machine.

Primary vs secondary hyperparathyroidism: the one difference that matters

In primary hyperparathyroidism, the fault lies in the gland. One or more parathyroid glands enlarge and release PTH regardless of how much calcium is already in the blood. The thermostat is stuck on. The NIDDK notes that in about 80 percent of people with the primary form, a single benign growth called an adenoma is responsible; in most of the remainder, two or more glands have enlarged, a pattern known as hyperplasia. Parathyroid cancer is rare, accounting for a very small fraction of cases, as MedlinePlus describes.

In secondary hyperparathyroidism, the glands are healthy and responding correctly. Something else has pulled calcium down or made it hard for the body to use, and the glands ramp up PTH to compensate. The furnace is running because the room really is cold. Chronic kidney disease and vitamin D deficiency are the usual culprits, and we will unpack both shortly.

Why does this change the treatment path so completely? Because removing or quieting a healthy, appropriately working gland does nothing for the underlying problem and can leave the person short of calcium. Conversely, treating vitamin D or kidney function in someone with a stuck-on adenoma will not switch that gland off. The intervention has to match the origin.

Here is an opinion grounded in the physiology: the most valuable thing a person newly told they have “high PTH” can do is ask which type, and why the team thinks so. That single question often reframes the entire conversation, from “will I need surgery” to “what is my calcium doing and what is driving it.” The answers to those two questions are, in most cases, sitting on the same lab report.

What are the two most common lab findings of primary hyperparathyroidism?

The signature pair is a blood calcium level above the reference range together with a PTH level that is elevated, or at least not suppressed the way it should be. In a healthy system, high calcium would drive PTH down toward the bottom of its range. Seeing both high at the same time tells the clinician the feedback loop has been broken at the gland. Mayo Clinic describes this combination as the usual basis for the diagnosis.

The word “inappropriately” carries weight here. A PTH result that sits in the upper part of the normal range can still be abnormal when calcium is high, because a normal gland would have gone quiet. Clinicians read the two values together rather than in isolation.

Supporting clues often accompany the main pair:

• Low blood phosphate, because PTH tells the kidneys to excrete it.
• Elevated calcium in a 24-hour urine collection, reflecting the excess spilling over.
• A vitamin D level, checked because deficiency can mask or exaggerate the picture.
• Kidney function tests, to rule out the secondary form and to gauge any damage.
• A bone density scan, since bone is where the calcium is being drawn from.

A less common variant, sometimes called normocalcemic primary hyperparathyroidism, shows persistently high PTH with calcium in the normal range and no other explanation. The evidence on how often this progresses and how it should be handled is still developing, and most guidance recommends careful confirmation and repeat testing before labeling it. If your team uses this term, it is reasonable to ask what they are ruling out and how they plan to follow the numbers over time.

What is the primary cause of secondary hyperparathyroidism?

Chronic kidney disease is the leading cause. As kidney function declines, two things happen at once. The kidneys lose their ability to clear phosphate, so phosphate builds up in the blood and binds calcium, lowering the free calcium level. At the same time, the kidneys make less of the enzyme that activates vitamin D, so the gut absorbs less calcium from food. Both changes push calcium down, and the parathyroid glands respond exactly as designed, by producing more PTH. Cleveland Clinic describes this kidney-driven form as the most common variety of secondary hyperparathyroidism, and it is a routine part of dialysis care.

Vitamin D deficiency on its own, even with normal kidneys, is the second major driver. Without enough vitamin D, dietary calcium passes through unabsorbed, and PTH rises to pull calcium from bone instead. Limited sun exposure, darker skin, older age, and certain digestive conditions all make deficiency more likely.

Other, less frequent causes share the same logic, a shortage of usable calcium:

• Malabsorption from celiac disease, inflammatory bowel disease, or after weight-loss surgery that bypasses part of the small intestine.
• Very low dietary calcium intake over a long period.
• Certain medicines by class, such as some anticonvulsants that speed up vitamin D breakdown, which a prescriber can review.

The practical consequence is that a secondary diagnosis is really a signpost pointing somewhere else. The parathyroid glands are the messenger, and the message is about the kidneys, the gut, or the skin’s vitamin D supply. Treatment that ignores the signpost and goes after the messenger tends to disappoint.

How do you tell primary from tertiary hyperparathyroidism?

Tertiary hyperparathyroidism is what can happen when the secondary form runs unchecked for years. Glands that have been working overtime through long-standing kidney disease gradually enlarge and, eventually, stop listening to calcium altogether. They become autonomous, behaving much like the adenoma of primary disease. On a lab report, tertiary and primary can look nearly identical: high calcium alongside high PTH.

The distinction lives in the history rather than in the numbers. A person with tertiary disease has a long record of chronic kidney disease, often years on dialysis, and frequently a kidney transplant in the recent past. After a transplant, the new kidney restores phosphate clearance and vitamin D activation, calcium rises, but the overgrown glands keep secreting because they have lost the ability to switch off. Cleveland Clinic notes that this post-transplant setting is where tertiary disease is most often recognized.

Someone with primary disease, by contrast, usually has normal or only mildly reduced kidney function and no such backstory. Their glands were never responding to a genuine calcium shortage.

Why does the label matter if the blood tests match? Because the treatment reasoning differs. In tertiary disease, the team is weighing the health of a transplanted kidney, the burden of bone disease accumulated over years, and typically the involvement of all four glands rather than one. Surgery, when it is considered, is more often a decision about how many glands to remove and whether to leave or re-implant a portion. In primary disease with a single adenoma, the surgical question is usually narrower. Same lab pattern, different conversation, which is precisely why clinicians read the chart before they read the report.

Hyperparathyroidism vs hypoparathyroidism: why the search results get tangled

A surprising number of people arrive at this topic having typed “primary and secondary hypoparathyroidism,” which is a different condition with an opposite problem. Hypoparathyroidism means too little PTH. It deserves a short detour because the two are so easily confused and because one can follow the other.

In primary hypoparathyroidism, the glands themselves are damaged or absent. The most common reason, according to Mayo Clinic, is injury to or removal of the glands during neck surgery, including thyroid or parathyroid operations. Autoimmune disease and certain genetic conditions account for most of the rest. Blood tests show low calcium and low PTH, the reverse of the hyperparathyroid pattern.

Secondary hypoparathyroidism is a term used less consistently. It usually describes a gland that is appropriately quiet because something else has pushed calcium high, such as excessive vitamin D intake or certain cancers that release calcium from bone. The gland is healthy; it has simply switched off in response. Some clinicians avoid the label altogether and describe the calcium problem directly.

The link back to our main topic is real: after surgery for hyperparathyroidism, calcium can dip temporarily while the remaining glands, which had been suppressed by the overactive one, wake up. In a minority of people this low-calcium state persists, becoming a form of hypoparathyroidism. That risk is one of the main reasons surgeons weigh how many glands to remove and why the days after an operation involve calcium monitoring.

So the honest answer to the tangled search is this: hyper means too much hormone and typically too much calcium; hypo means too little of both. Each has its own primary and secondary logic, and each has its own path.

Primary vs secondary hyperparathyroidism at a glance

Words can only carry so much of this. The table below lines up the two main forms, with the tertiary form added because it borrows features from both. Reference ranges vary between laboratories, so the entries describe direction rather than numbers.

Feature	Primary	Secondary	Tertiary
Where the problem starts	In the parathyroid gland (adenoma or hyperplasia)	Outside the gland (kidney, vitamin D, gut)	Gland becomes autonomous after long-standing secondary disease
Blood calcium	High	Low or normal	High
PTH	High or not suppressed	High	High
Blood phosphate	Often low	Often high in kidney disease	Variable
Typical background	Otherwise well, more common in women over 50	Chronic kidney disease, vitamin D deficiency, malabsorption	Years of kidney disease, often after transplant
First treatment focus	The gland itself; surgery or monitoring	The underlying cause	Often the glands, with kidney and bone health weighed together
Number of glands usually involved	One in most cases	All four, reactively	All four, enlarged

Two patterns stand out. The calcium row is the quickest sorting tool: high calcium points toward primary or tertiary, while low-to-normal calcium with high PTH points toward secondary. And the treatment row shows the logic that runs through this whole article. Where the problem starts is where treatment starts.

A table cannot capture the exceptions. Vitamin D deficiency can coexist with a primary adenoma and blunt the calcium rise. Early kidney disease can sit alongside primary disease in an older adult. Sorting those overlaps is why endocrinologists, nephrologists, and surgeons often share a single patient, and why repeat testing is more common than people expect.

Who is usually offered parathyroid surgery, and who is asked to watch and wait

For primary hyperparathyroidism, surgery to remove the overactive gland or glands is the only treatment that addresses the source, and international guidance has converged on a set of situations where it is generally recommended. Mayo Clinic summarizes the common threads: symptoms attributable to high calcium, kidney stones or reduced kidney function, osteoporosis or a fragility fracture, a calcium level well above the upper limit of normal, and younger age at diagnosis, typically under 50, because the cumulative exposure to high calcium over a lifetime is greater.

People who fit none of those criteria, whose calcium is only mildly raised and whose bones and kidneys look healthy, are often offered monitoring instead. This is not neglect. Long-term observational studies summarized by the NIDDK suggest that many people with mild, asymptomatic disease remain stable for years. Monitoring usually means periodic blood calcium and kidney function checks, bone density scans at intervals, and a low threshold to revisit surgery if any measure worsens.

Some people meet surgical criteria but are asked to wait or to consider alternatives for other reasons: significant heart or lung disease that raises anesthetic risk, a previous neck operation that makes a repeat approach more complex, or imaging that cannot locate the culprit gland. In those cases the team may discuss medicines that lower calcium or protect bone, described in a later section, while the decision is revisited.

For secondary hyperparathyroidism, surgery is uncommon and reserved for severe, persistent cases, usually in long-term dialysis, where the glands have stopped responding to medical treatment. Removing reactive glands in someone whose calcium is already low or normal risks making the calcium problem worse.

Whatever the category, the decision rests with the treating team, who weigh the labs against the whole person. A reasonable patient question is simply: “Which of these criteria apply to me, and which do not?”

What parathyroid surgery involves, step by step

Before an operation for primary disease, the surgeon wants to know which gland is the problem. Two imaging tests are common. A sestamibi scan uses a small amount of a radioactive tracer that overactive parathyroid tissue takes up more avidly than normal tissue, lighting it up on a camera. Neck ultrasound looks for an enlarged gland directly. Some centers add a specialized CT scan that captures the neck at several time points. NHS guidance notes that imaging is used to plan the approach rather than to make the diagnosis, which rests on the blood tests.

If imaging clearly shows a single enlarged gland, many surgeons perform a focused operation through a small incision, removing only that gland. If imaging is unclear, or if the diagnosis suggests several glands are involved, the surgeon may explore both sides of the neck and inspect all four. During either approach, a rapid PTH blood test can be run in the operating room; because PTH clears from the blood within minutes, a sharp drop after removal suggests the overactive tissue has been found.

The operation is usually done under general anesthesia. Cleveland Clinic notes that most people go home the same day or after one night.

Risks are described in neutral terms in every consent conversation and include:

• Temporary or, less often, lasting low calcium as the remaining glands recover.
• Hoarseness or voice change from irritation or injury to the nerves that run beside the glands.
• Bleeding or infection at the incision site.
• Failure to find or remove all overactive tissue, requiring further tests or a second operation.

Alternatives to surgery for primary disease are monitoring, medicines that lower calcium or protect bone, and attention to hydration and activity. None of these removes the gland, and the trade-offs are a conversation for the individual and their team.

Why treating secondary hyperparathyroidism means treating the trigger first

When the glands are healthy and simply responding to a shortage, the goal is to end the shortage. What that looks like depends on the cause.

Where vitamin D deficiency is the driver and kidneys are working, repleting vitamin D under medical supervision allows calcium absorption to recover and PTH to settle back down. The NIH Office of Dietary Supplements describes how vitamin D supports calcium absorption, and clinicians typically recheck levels after a course of treatment rather than assuming the correction has worked. The amount and duration are decisions for the prescriber, because too much vitamin D carries its own risk of high calcium.

Where chronic kidney disease is the driver, the approach is broader and usually managed by a kidney specialist. Several medicine classes may be discussed, each acting on a different part of the loop:

• Phosphate binders, taken with meals, trap dietary phosphate in the gut so less enters the blood.
• Active vitamin D compounds bypass the failing kidney’s activation step and help suppress PTH directly.
• Calcimimetics mimic calcium at the parathyroid gland’s calcium-sensing receptor, effectively telling the gland that calcium is adequate so it releases less PTH.

Dietary phosphate guidance, dialysis adjustments, and treatment of the kidney disease itself run alongside these. Improvement is measured over weeks to months of repeated blood tests rather than days, and targets are individualized because dialysis guidelines accept a wider PTH range than laboratories list as “normal.”

Where malabsorption is the cause, treating the digestive condition or adjusting how nutrients are delivered addresses the root. In every version, the message is the same: the parathyroid glands are reporting a problem, and the treatment path follows the report back to its source. Surgery enters the conversation only when years of that approach have failed to hold PTH in check.

What the days and weeks after treatment usually look like

After parathyroid surgery for primary disease, the first few days revolve around calcium. The remaining glands have often been suppressed for months or years by the overactive one, and they may take time to resume normal work. Cleveland Clinic and NHS guidance both describe tingling around the lips or fingertips and muscle cramps as the typical signs of a temporary calcium dip, and teams usually give clear instructions on what to watch for and when to call. Many people are asked to take a calcium supplement for a period, on a plan set by the surgical team, with blood tests to guide when to taper.

The incision is small and usually healed enough for normal activity within a couple of weeks; the NHS notes that most people recover quickly and that any voice change is usually temporary. Bone density tends to improve over the following year or two as the skeleton stops losing calcium, though the extent varies and is tracked by repeat scans rather than assumed.

Someone who has lived for years with very active bone turnover can experience a more pronounced and longer calcium dip after surgery, sometimes called hungry bone syndrome, as the skeleton rapidly pulls calcium back in. This is more common after operations for tertiary disease and is one reason those recoveries are monitored more closely.

For secondary hyperparathyroidism treated medically, there is no single recovery moment. Vitamin D repletion is typically followed by a repeat blood test after several weeks. In kidney disease, PTH, calcium, and phosphate are checked at regular intervals as part of ongoing care, and medicine classes are adjusted by the nephrology team in response. Progress is a trend line, not a finish line.

Whichever path applies, the team sets the follow-up schedule, and it is reasonable to ask for it in writing before leaving the clinic.

What people often get wrong about hyperparathyroidism

“It’s a thyroid problem.” The glands share a neighborhood and half a name, nothing more. Thyroid hormone tests can be completely normal in someone with severe parathyroid disease, and thyroid treatment does not touch calcium regulation.

“High calcium means I should cut calcium from my diet.” In primary disease, the excess calcium in the blood comes mostly from bone, not from food. Mayo Clinic advises against severe dietary restriction because the skeleton is already being depleted. In secondary disease, dietary calcium and vitamin D are often part of the solution rather than the problem. Any change to intake belongs in a conversation with the treating team.

“If I feel fine, nothing is happening.” Hyperparathyroidism is frequently found on routine bloodwork in people with no complaints. Bone loss and kidney stone formation are silent for a long time, which is exactly why monitoring involves scans and urine tests rather than a symptom diary.

“A normal PTH rules it out.” A PTH value inside the reference range can still be inappropriate if calcium is high, because a healthy gland would have shut down. The two numbers must be read together.

“Secondary means milder.” The labels describe origin, not severity. Secondary disease in advanced kidney failure can cause more bone and blood vessel damage than a small primary adenoma. Conversely, mild primary disease can be stable for years.

“Surgery is a quick fix I can decide on from the scan.” Imaging finds the gland; it does not make the diagnosis and does not by itself justify an operation. Guidelines base the decision on calcium levels, bone and kidney health, age, and symptoms, all weighed by the team.

“Once treated, I’m done.” Even after a successful operation, follow-up calcium checks continue, and in secondary disease the underlying condition still needs care.

Questions to ask your care team

Good questions do more than gather information; they signal what matters to you and often reshape the plan. Take these into the appointment, and add your own.

• Which type do you believe I have, primary, secondary, or tertiary, and which results led you there?
• Have my vitamin D level and kidney function been checked, and could either be contributing?
• What is my calcium doing over time, and how many measurements do we have?
• Has a bone density scan been done, and what did it show?
• Do I meet any of the usual criteria for surgery, and which ones do I not meet?
• If monitoring is the plan, how often will we repeat tests, and what change would prompt a different decision?
• If surgery is discussed, what imaging will be used to locate the gland, and what happens if it cannot be found?
• What are the specific risks of the operation in my case, and how are they managed afterward?
• If medicines are proposed, what part of the calcium loop does each one act on, and how will we know it is working?
• Who coordinates my care if more than one specialist is involved?
• What symptoms after treatment should prompt a same-day call?

One more, often overlooked: “What would you want to know if you were in my position?” Clinicians tend to answer that candidly, and the answer frequently surfaces the trade-off they consider most important.

Write the answers down, or ask whether a summary can be added to your patient portal. The distinction between primary and secondary disease can be genuinely confusing to hold in your head during a short visit, and having the reasoning on paper makes the next appointment far more productive. None of these questions has a single correct answer; they are prompts for a shared decision with the people who know your full history.

When to call your doctor

Most people with hyperparathyroidism, whichever type, move through diagnosis and treatment without emergencies. A few situations do warrant a prompt call or an urgent visit, and knowing them in advance removes guesswork.

Call your care team the same day if you notice:

• Tingling or numbness around the mouth, in the fingers, or in the toes, or muscle cramps and twitching, particularly in the days after parathyroid surgery. These can signal that calcium has fallen too low.
• New or worsening hoarseness, trouble swallowing, or a feeling of tightness in the neck after surgery.
• Swelling, spreading redness, or discharge at the incision.
• Severe flank or back pain with blood in the urine, which may indicate a kidney stone.
• Persistent nausea and vomiting, marked thirst with frequent urination, or new confusion, drowsiness, or unusual weakness. These can accompany a sharp rise in calcium and need same-day assessment.

Seek emergency care immediately for chest pain, difficulty breathing, a rapidly enlarging neck swelling after surgery, a seizure, or a sudden change in consciousness. The NHS and Mayo Clinic both list severe high calcium as a situation requiring urgent treatment.

For people managing secondary disease through kidney care, the dialysis or nephrology team usually provides its own contact pathway for changes in symptoms or missed treatments; use it.

Between those extremes, do not hesitate to call for things that simply worry you: a lab result you do not understand, a medicine side effect, or a symptom that has crept up over weeks. The treating team would rather hear from you early. Every decision about testing, timing, and treatment stays with them, and a call is often the quickest way to keep it there.

Frequently asked questions

How do you differentiate primary from secondary hyperparathyroidism on a blood test?

The calcium level is the quickest sorting tool. Primary disease shows high calcium together with a PTH that is raised or not suppressed, because the gland has stopped responding to feedback. Secondary disease shows low or normal calcium with a high PTH, because the gland is correctly compensating for a shortage. Clinicians confirm the picture with vitamin D, kidney function, and phosphate results and often repeat the tests before settling on a label.

What are the two most common lab findings of primary hyperparathyroidism?

Elevated blood calcium and an elevated, or inappropriately normal, parathyroid hormone level. In a healthy system high calcium would push PTH toward the bottom of its range, so seeing both high at once points to a gland that has stopped listening. Supporting findings can include low phosphate, high urine calcium, and reduced bone density, but the calcium-PTH pair carries the diagnosis according to Mayo Clinic.

What is the primary cause of secondary hyperparathyroidism?

Chronic kidney disease. Failing kidneys retain phosphate, which binds calcium and lowers the free level, and they make less active vitamin D, so the gut absorbs less calcium. Both changes push the parathyroid glands to release more PTH. Vitamin D deficiency with normal kidneys is the second major cause, followed by malabsorption conditions such as celiac disease or the aftermath of some digestive surgeries.

How do you differentiate between primary and tertiary hyperparathyroidism?

By history rather than by the lab pattern, which is often identical: high calcium with high PTH. Tertiary disease develops after years of secondary disease, almost always in long-standing kidney failure, and is frequently unmasked after a kidney transplant restores kidney function while the overgrown glands keep secreting. Primary disease arises in a person without that backstory, usually with a single adenoma rather than four enlarged glands.

What is the difference between hyperparathyroidism vs hypoparathyroidism?

Hyperparathyroidism means too much parathyroid hormone, usually with high blood calcium. Hypoparathyroidism means too little hormone and low calcium, most often after the glands are damaged or removed during neck surgery, according to Mayo Clinic. The two can be linked: after surgery for an overactive gland, the remaining glands sometimes take time to recover, causing a temporary or occasionally lasting low-calcium state that is monitored closely.

What are the most common secondary hyperparathyroidism causes besides kidney disease?

Vitamin D deficiency is the leading non-kidney cause, since without enough vitamin D the gut absorbs little dietary calcium and PTH rises to draw calcium from bone. Malabsorption from celiac disease, inflammatory bowel disease, or weight-loss surgery that bypasses part of the intestine can do the same. Very low long-term calcium intake and certain medicine classes that speed vitamin D breakdown are less common contributors a prescriber can review.

Which primary hyperparathyroidism lab findings do doctors check before recommending surgery?

Beyond the calcium and PTH pair, teams typically look at kidney function, a 24-hour urine calcium, vitamin D level, and a bone density scan. Guidelines summarized by Mayo Clinic tie surgical recommendations to markedly raised calcium, reduced kidney function or stones, osteoporosis or fracture, symptoms, and age under 50. Imaging such as a sestamibi scan or ultrasound is used to locate the gland, not to decide whether an operation is warranted.

Can secondary hyperparathyroidism be treated without surgery?

Usually, yes. Because the glands are responding to a shortage rather than malfunctioning, treatment aims at the shortage: vitamin D repletion when deficiency is the driver, and in kidney disease a combination of phosphate control, active vitamin D compounds, and calcimimetic medicines that signal the gland to release less PTH. Surgery is generally reserved for severe cases in long-term dialysis where those measures have failed, and the decision sits with the nephrology and surgical teams.

What happens to calcium after parathyroid surgery?

It commonly dips for a period. The remaining glands have often been suppressed by the overactive one and may take days to weeks to resume normal output, so many people are given calcium supplements on a plan set by their team and have blood tests to guide tapering. Tingling around the lips or in the fingertips, or muscle cramps, are the usual signs of low calcium and warrant a same-day call, as NHS guidance describes.

Does mild primary hyperparathyroidism always need treatment?

No. People with mildly raised calcium, no symptoms, and healthy bones and kidneys are often offered monitoring rather than surgery. The NIDDK notes that many such people remain stable for years. Monitoring typically involves periodic calcium and kidney function tests and bone density scans at intervals, with a low threshold to revisit surgery if any measure worsens. The choice between observation and operation is made with the treating team.

References

• Primary Hyperparathyroidism – National Institute of Diabetes and Digestive and Kidney Diseases (NIH)
• Hyperparathyroidism – NHS
• Hyperparathyroidism – MedlinePlus Medical Encyclopedia
• Hyperparathyroidism – Cleveland Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.